Increase lab productivity in cell and gene therapy with Gyrolab® miniaturized ELISA technology

Increase lab productivity in cell and gene therapy with
Gyrolab® miniaturized ELISA technology

 

Using an affinity flow-through format, highly reproducible nanoliter microfluidics, and parallel processing, the Gyrolab platform simplifies assay workflows and shortens run times while delivering high-quality immunoassay data.

Whether you’re looking for a complete system, a kit, or components, our platforms miniaturize, integrate, and automate your sample analysis at scale, maximizing your productivity and helping your lab make data-driven decisions – fast.

 

Gyrolab − Proprietary CD technology that delivers results

  • One-hour, high precision automated immunoassays

  • Low sample and reagent consumption

  • Exceptional reproducibility

  • Flexible assay format, plug-and-play kits, custom assay development, own reagents.

Gyrolab automated systems
Plug-and-play kits and solutions
Custom kit development
assays with your own reagents

Cell & Gene Thereapy Resources

Webinars

Tuesday April 18th

Zhe Liu, webinar

Familiar with the challenge of monitoring the concentration of a transgene product when true reference material is missing. Listen to this online webinar to learn how Alliance has addressed this challenge.

Webinar on demand

 

Publications

Anti-drug antibody studies — how to maximize drug tolerance and minimize sample

Anti-drug antibody studies — how to maximize drug tolerance and minimize sample

This White Paper presents case studies describing how Gyrolab® platform meets the productivity and sensitivity demands of ADA analysis in biopharmaceutical preclinical and clinical studies.

Download the white paper
Microfluidic, one-hour, total anti-AAV2 antibody assay inhuman serum using Gyrolab® platform

Microfluidic, one-hour, total anti-AAV2 antibody assay inhuman serum using Gyrolab® platform

This poster presents the development of an immunoassay for the detection of total AAV2 anti-capsid antibodies (TAbs) using the Gyrolab® platform, for rapid and accurate rapid and accurate measurement of immunogenicity against adeno-associated viral (AAV) vector serotypes.”

Download the poster
Increasing productivity in cell and gene therapy bioprocessing with fast and reliable immunoassays

Increasing productivity in cell and gene therapy bioprocessing with fast and reliable immunoassays

This white paper provides an overview of the viral vector landscape and its use in cell and gene therapy and discusses requirements for immunoassays in viral vector bioprocess analytics.

Download the white paper
High-throughput, automated analysis of viral vector titer and process-related impurities

High-throughput, automated analysis of viral vector titer and process-related impurities

Vector production results in a small volume of highly valuable products yet sample analysis during bioprocess steps can consume up to one-half of a production batch. This application note illustrates how the Gyrolab platform significantly saves hands-on time and sample volume for titer and impurity immunoassays compared to manual ELISA or other plate-based methods in titer and impurity immunoassays.

Download the application note

Testimonials of why our customers prefer Gyrolab over ELISA

Testimonials of why our customers prefer Gyrolab over ELISA

”Improved dynamic range resulting in less repeat testing and potentially more accurate results”

“Less sample volume required per test replicate (8 μL vs 200 μL)”

“Improved turn-around-time (1-hour vs 4-hour)”

New to the Gyrolab technology

 

The Gyrolab technology is a powerful way to increase productivity of immunoassays, generate reproducible data and make data-driven decisions more quickly.

View the introduction to the Gyrolab platform

 

Follow us on LI
YouTube